← Eichor
Study identifier: NCT03625011 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Gabapentin Premedication to Reduce Postoperative Pain for Pediatric Tonsillectomy

Condition: Tonsillitis · Tonsillectomy  ·  Sponsor: Children's Healthcare of Atlanta

PhasePhase 4
Planned participants50
Who can joinAll sexes, 3 Years to 18 Years
Healthy volunteersYes

About this study

The purpose of this pilot study: 1) to examine the use of gabapentin in reducing pain in the first 48 hours postoperatively including the total amount of narcotics mg/kg given 2) to record the time to first analgesic postoperatively and 3) to compare Wong Baker and the 0-10 numeric pain distress scale scores at 12, 24 and 48 hours postoperatively. We hypothesize one 15mg/kg (up to 600mg) dose of gabapentin will decrease mean narcotic amounts in mg/kg compared to participants who do not receive preoperative gabapentin and will demonstrate a decreased mean time to first analgesic as well as to lower mean pain scores for each age group at 12, 24 and 48 hours.

This description comes directly from the study's public registry record.

Talk to the study team

Beena Desai  ·  404-785-2269  ·  beena.desai@choa.org

Margaret A Gettis, DNP,CPNP-PC  ·  404-785-8622  ·  margaret.gettis@choa.org

Always discuss trial participation with your own doctor first.

Locations (1)

Children's Healthcare of AtlantaAtlanta, Georgia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03625011